InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Conterno Enrique A, Chief Executive Officer. Director active across 1 companies, notably FIBROGEN INC. In total, 10 filings have been recorded. The latest transaction was filed on 6 June 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations10 total
€15,7451,772 shares@ €8.88566.0% of flow
Common Stock
SEC:0001209191-22-035219:0·
€15,3611,311 shares@ €11.71675.8% of flow
Common Stock
SEC:0001209191-22-023840:0·
€82,6327,081 shares@ €11.669531.4% of flow
Common Stock
SEC:0001209191-22-017646:0·
0179,400 shares0
Common Stock
SEC:0001209191-22-010447:0·
€18,9121,536 shares@ €12.312725.3% of flow
Common Stock
SEC:0001209191-22-002496·
€18,9121,536 shares@ €12.31277.2% of flow
Common Stock
SEC:0001209191-22-002496:0·
€16,4101,859 shares@ €8.827122.0% of flow
Common Stock
SEC:0001209191-21-060056·
€16,4101,859 shares@ €8.82716.2% of flow
Common Stock
SEC:0001209191-21-060056:0·
€39,3981,859 shares@ €21.193252.7% of flow
Common Stock
SEC:0001209191-21-046078·
€39,3981,859 shares@ €21.193215.0% of flow
Common Stock
SEC:0001209191-21-046078:0·
10 of 10 declarations
About Conterno Enrique A
Enrique A. Conterno is the Chief Executive Officer of FibroGen Inc. He is responsible for the strategic direction of the company and overseeing its operations. His leadership is essential for achieving FibroGen's growth and innovation objectives.
